drugset / Trial / NCT00454181

Treatment of Oral Warts in HIV+ Patients

NCT00454181

Phase 2 Completed 59 enrolled Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a study to test lozenges of interferon-alpha that are dissolved in the mouth as a treatment of oral warts in HIV-positive adults. The hypothesis of this study is that interferon-alpha will be safe and that a higher percentage of subjects given interferon-alpha will experience a complete or nearly complete remission of their oral warts compared to subjects given placebo.

Timeline

Start
2007-02
Primary completion
2009-09
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject interferon alfa-2b Protein / enzyme biologic 500 iu Other